Total Funding
37
62
Total FundingVenture - Series Unknown raised
Growth Score
-7 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
111360
Medicinal Genomics is pioneering the genomics of medical cannabis and hemp.
Acquired by 
Courtagen Life Sciences
Brendan McKernan: Chief Executive Officer and Board MemberPast Role: Courtagen Life Sciences, Co-founder & President, Director
Kevin McKernan: Founder, CEOPast Role: Applied Biosystems, Distinguished Scientific Fellow
About the Company
Medicinal Genomics is pioneering the genomics of medical cannabis and hemp. In 2011, Medicinal Genomics made worldwide headlines for being the first group to decode the Cannabis Genome. An increasing amount of scientific evidence supports the theory that cannabinoid compounds may have numerous medical benefits. Medicinal Genomics has the largest
DNA sequence database of the cannabis plant and is well-positioned to design fingerprinting assays for strain genotyping and sequencing services for strain development. In 2011, Medicinal Genomics was acquired by Courtagen Life Sciences, Inc.
